Home / Inspections / 881778

FDA Inspection 881778 — Ari-Med Pharmaceuticals

Ari-Med Pharmaceuticals — FEI 2027206

The FDA completed an inspection of Ari-Med Pharmaceuticals on June 2, 2014 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 2, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tempe, AZ (United States)

Facility

Other inspections at this facility

  • 1111694 (NAI Thu Oct 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075268 (NAI Thu Nov 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988721 (VAI Wed Aug 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 726129 (NAI Mon May 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 648012 (NAI Mon Feb 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources